General Atlantic, KKR, others in talks to buy majority stake in AIMS: Report

AIMS has a team of over 1,100 doctors and 4,500 trained professionals, specialising in more than 24 medical fields.

General Atlantic, KKR and another four to five private equity (PE) firms are competing for a majority stake in Faridabad-based hospital chain Asian Institute of Medical Sciences (AIMS), The Economic Times has reported.

The potential deal is expected to value the 1,200-bed hospital chain at Rs 1,500 crore. Chennai-based Veda Capital has been hired to run the sale process, it said.

Moneycontrol couldn't independently verify the report.

Others in the race include Singapore-based Growtheum Capital and Asia-focused fund Everstone Capital. India Resurgence Fund (IndiaRF), backed by Piramal Enterprises and Bain Capital, also explored the deal but eventually withdrew, the report added.

Also Read | KKR to acquire India's Healthium Medtech from Apax Partners

US-based PE firm OrbiMed and British International Investment (BII) collectively own a 49 percent stake in the hospital chain.

Promoter Dr Narendra Kumar Pandey and family hold the rest. Promoters, too, are selling a minority stake in AIMS with the exact portion subject to the company's final valuation, the report stated.

AIMS has a team of over 1,100 doctors and 4,500 trained professionals, specialising in more than 24 medical fields.

"This is true that OrbiMed and BII as our previous investors are in the process of exit," an AIMS spokesperson told ET without sharing the details.

KKR, General Atlantic, India RF and BII's spokespersons declined comment, while mails sent to OrbiMed and Growtheum Capital did not elicit any response, the report said.

AIMS has a presence in Uttar Pradesh, Jharkhand and Bihar.